“I agree on the 47 and I believe it was in the M
Post# of 148154
No, the 47 patient trial was the combo trial. See PR below. The mono trial is the larger, 500 patient trial with multiple doses.
https://www.cytodyn.com/newsroom/press-releas...ed-pivotal
“Closet, do you have proof from a CYDY document that the receptor occupancy testing was part of the protocol at the start of the trial?”
To clarify, I don’t know if RO was part of the combo or mono trial protocols. I suspect he wasn’t, but that doesn’t prevent the FDA from requesting it.